A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

Authors: Blay, J.-Y. ^{1, ∗}, Schiffler, C. ¹, Bouché, O. ², Brahmi, M. ¹, Duffaud, F. ³, Toulmonde, M. ⁴, Landi, B. ⁵, Lahlou, W. ⁵, Pannier, D. ⁶, Bompas, E. ⁷, Bertucci, F. ⁸, Chaigneau, L. ⁹, Collard, O. ¹⁰, Pracht, M. ¹¹, Henon, C. ¹², Ray-Coquard, I. ¹, Armoun, K. ², Salas, S. ³, Spalato-Ceruso, M. ⁴, Adenis, A. ^{6, 13}, Verret, B. ¹³, Penel, N. ⁶, Moreau-Bachelard, C. ⁷, Italiano, A. ⁴, Dufresne, A. ¹, Metzger, S. ¹, Chabaud, S. ¹, Perol, D. ¹, Le Cesne, A. ¹²

Source: In Annals of Oncology December 2024 35(12):1157-1168

Role of the primary care physician in skin cancer screening: Perspectives of skin cancer patients

Authors: Belkaïd, S., Schenck, M., Marcoux, M., Chabaud, S., Darnis, S., Amini-Adle, M.

Source: In Annales de Dermatologie et de Vénéréologie September 2024 151(3)

Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma

Authors: Dufresne, A. ^{1, ∗}, Pokras, S. ², Meurgey, A. ³, Chabaud, S. ⁴, Toulmonde, M. ⁵, Bompas, E. ⁶, Le Cesne, A. ⁷, Robin, Y.-M. ⁸, Duffaud, F. ⁹, Valentin, T. ¹⁰, El Zein, S. ¹¹, Leroux, A. ¹², Dubray-Longeras, P. ¹³, Firmin, N. ¹⁴, de Pinieux, G. ¹⁵, Noal, S. ¹⁶, Delfour, C. ¹⁷, Bollard, J. ¹⁸, Tonon, L. ¹⁹, Biette, A. ²⁰, Gadot, N. ²¹, Attignon, V. ¹⁸, Jean-Denis, M. ²⁰, Woessner, M. ², Klohe, E. ², Thayaparan, T. ², Eleftheriadou, I. ², Blouch, K. ^{2, †}, Nathenson, M.J. ^{2, ‡}, Blay, J.-Y. ¹

Source: In ESMO Open August 2024 9(8)

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial

Authors: Penault-Llorca, F., Dalenc, F., Chabaud, S., Cottu, P., Allouache, D., Cameron, D., Grenier, J., Venat Bouvet, L., Jegannathen, A., Campone, M., Debled, M., Hardy-Bessard, A.-C., Giacchetti, S., Barthelemy, P., Kaluzinski, L., Mailliez, A., Mouret-Reynier, M.-A., Legouffe, E., Cayre, A., Martinez, M., Delbaldo, C., Mollon-Grange, D., Macaskill, E.J., Sephton, M., Stefani, L., Belgadi, B., Winter, M., Orfeuvre, H., Lacroix-Triki, M., Bonnefoi, H., Bliss, J., Canon, J.-L., Lemonnier, J., Andre, F., Bachelot, T.

Source: In ESMO Open May 2024 9(5)

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors

Authors: Heudel, P.E., de Montfort, A., Debieuvre, D., Chouaid, C., Carton, M., Audigier-Valette, C., Filleron, T., Chabaud, S., Stancu, A., Quantin, X., Hiret, S., Bosquet, L., Blay, J.Y.

Source: In Lung Cancer August 2023 182

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study

Authors: Le Cesne, A., Chevreau, C., Perrin, C., Italiano, A., Hervieu, A., Blay, J.Y., Piperno-Neumann, S., Saada-Bouzid, E., Bertucci, F., Firmin, N., Kalbacher, E., Narciso, B., Schiffler, C., Yara, S., Jimenez, M., Bouvier, C., Vidal, V., Chabaud, S., Duffaud, F.

Source: In ESMO Open June 2023 8(3)

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

Authors: Dano, D., Lardy-Cleaud, A., Monneur, A., Quenel-Tueux, N., Levy, C., Mouret-Reynier, M.-A., Coudert, B., Mailliez, A., Ferrero, J.-M., Guiu, S., Campone, M., de La Motte Rouge, T., Petit, T., Pistilli, B., Dalenc, F., Simon, G., Lerebours, F., Chabaud, S., Bertucci, F., Gonçalves, A.

Source: In ESMO Open August 2021 6(4)

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

Authors: Blay, J.Y., Boucher, S., Le Vu, B., Cropet, C., Chabaud, S., Perol, D., Barranger, E., Campone, M., Conroy, T., Coutant, C., De Crevoisier, R., Debreuve-Theresette, A., Delord, J.P., Fumoleau, P., Gentil, J., Gomez, F., Guerin, O., Jaffré, A., Lartigau, E., Lemoine, C., Mahe, M.A., Mahon, F.X., Mathieu-Daude, H., Merrouche, Y., Penault-Llorca, F., Pivot, X., Soria, J.C., Thomas, G., Vera, P., Vermeulin, T., Viens, P., Ychou, M., Beaupere, S.

Source: In ESMO Open June 2021 6(3)

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Authors: Adelstein, D.J., Agarwal, J., Alfonsi, M., Argiris, A., Aupérin, A., Bacigalupo, A., Bar-Ad, V., Bartelink, H., Beadle, B., Belkacemi, Y., Bensadoun, R.J., Bernier, J., Blanchard, P., Bourhis, J., Bratland, Å., Brizel, D., Budach, V., Budach, W., Burtness, B., Calais, G., Campbell, B., Caudell, J., Chabaud, S., Chamorey, E., Chaukar, D., Cheugoua-Zanetsie, M., Cho, K.H., Choussy, O., Cruz Hernandez, J.J., Denham, J.W., Dobrowsky, W., Dominello, M.M, Driessen, C.M.L., Fallai, C., Forastiere, A.A., Fortpied, C., Fountzilas, G., Garaud, P., Garden, A.S., Gery, B., Ghadjar, P., Ghi, M.G., Ghosh Laskar, S., Graff-Cailleaud, P., Grau, C., Gregoire, V., Hackshaw, A., Haddad, E, Haffty, B.G., Hansen, A., Hay, J.H., Hayoz, S., Horiot, J.C., Hitt, R., Jeremic, B., Johansen, J., Jones, C., Julieron, M., Kristensen, C.A., Kumar, S., Lacas, B., Langendijk, J.A., Lapeyre, M., Lartigau, E., Licitra, L., Le, Q.T., Lee, J.W., Lee, P., Lewin, F., Li, Y., Lopes, A., Lotayef, M., Maciejewski, B., Mazeron, J.J., Mehta, S., Michalski, W., Moon, J., Moon, S.H., Moyal, E., Nankivell, M., Nilsson, P., Olmi, P., Orecchia, R., O'Sullivan, B., Overgaard, J., Parmar, M.K.B., Petit, C., Pignon, J.P., Pointreau, Y., Posner, M.R., Poulsen, M.G., Quon, H., Racadot, S., Rosenthal, D.I., Rovea, P., Ruo Redda, M.G., Sanguineti, G., Shenouda, G., Simes, J., Sharma, A., Simon, C., Sire, C., Skladowski, K., Spencer, S., Staar, S., Strojan, P., Stromberger, C., Suwinski, R., Szutkowski, Z., Takácsi-Nagy, Z., Tao, Y.G., Temam, S., Thomson, D., Tobias, J.S., Torres-Saavedra, P., Torri, V., Tripcony, L., Trotti, A., Tseroni, V., van Herpen, C., van Tinteren, H., Vermorken, J., Viegas, C.M.P., Vokes, E.E., Waldron, J., Wernecke, K.D, Widder, J., Wolf, G.T., Wong, S.J., Wu, J.S., Yamazaki, H., Zaktonik, B., Zackrisson, B., Zhong, L.P., Petit, Claire, Lacas, Benjamin, Pignon, Jean-Pierre, Le, Quynh Thu, Grégoire, Vincent, Grau, Cai, Hackshaw, Allan, Zackrisson, Björn, Parmar, Mahesh K B, Lee, Ju-Whei, Ghi, Maria Grazia, Sanguineti, Giuseppe, Temam, Stéphane, Cheugoua-Zanetsie, Maurice, O'Sullivan, Brian, Posner, Marshall R, Vokes, Everett E, Cruz Hernandez, Juan J, Szutkowski, Zbigniew, Lartigau, Eric, Budach, Volker, Suwiński, Rafal, Poulsen, Michael, Kumar, Shaleen, Ghosh Laskar, Sarbani, Mazeron, Jean-Jacques, Jeremic, Branislav, Simes, John, Zhong, Lai-Ping, Overgaard, Jens, Fortpied, Catherine, Torres-Saavedra, Pedro, Bourhis, Jean, Aupérin, Anne, Blanchard, Pierre ^*

Source: In The Lancet Oncology May 2021 22(5):727-736

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Authors: Adelstein, D.J., Alfonsi, M., Belkacemi, Y., Bar-Ad, V., Bernier, J., Bratland, Å., Calais, G., Campbell, B., Caudell, J., Chabaud, S., Chamorey, E., Chaukar, D., Choi, K.N., Choussy, O., Collette, L., Cruz, J.J., Dani, C., Dauzier, E., Forastiere, A.A., Garaud, P., Gregoire, V., Hackshaw, A., Haddad, E., Haffty, B.G., Hansen, A., Hayoz, S., Horiot, J.C., Jeremic, B., Karrison, T.G., Langendijk, J.A., Lapeyre, M., Lartigau, E., Leong, T., Le, Q.T., Lee, P.P.Y., Lewin, F., Lin, A., Lopes, A., Mehta, S., Moon, J., Moyal, E., Occéan, B.V., Olmi, P., Orecchia, R., O'Sullivan, B., Overgaard, J., Petit, C., Quon, H., Sanguineti, G., Satar, T., Simes, J., Simon, C., Sire, C., Staar, S., Stromberger, C., Strojan, P., Temam, S., Thomson, D., Timochenko, A., Torri, V., Tseroni, V., Vermorken, J., Vokes, E.E., Waldron, J., Wernecke, K.D., Widder, J., Zackrisson, B., Lacas, Benjamin, Carmel, Alexandra, Landais, Cécile, Wong, Stuart J., Licitra, Lisa, Tobias, Jeffrey S., Burtness, Barbara, Ghi, Maria Grazia, Cohen, Ezra E.W., Grau, Cai, Wolf, Gregory, Hitt, Ricardo, Corvò, Renzo, Budach, Volker, Kumar, Shaleen, Laskar, Sarbani Ghosh, Mazeron, Jean-Jacques, Zhong, Lai-Ping, Dobrowsky, Werner, Ghadjar, Pirus, Fallai, Carlo, Zakotnik, Branko, Sharma, Atul, Bensadoun, René-Jean, Ruo Redda, Maria Grazia, Racadot, Séverine, Fountzilas, George, Brizel, David, Rovea, Paolo, Argiris, Athanassios, Nagy, Zoltán Takácsi, Lee, Ju-Whei, Fortpied, Catherine, Harris, Jonathan, Bourhis, Jean, Aupérin, Anne, Blanchard, Pierre, Pignon, Jean-Pierre

Source: In Radiotherapy and Oncology March 2021 156:281-293

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer

Authors: Heudel, P., Chabaud, S., Perol, D., Flechon, A., Fayette, J., Combemale, P., Tredan, O., Desseigne, F., de la Fouchardiere, C., Boyle, H., Perol, M., Bachelot, T., Cassier, P., Avrillon, V., Terret, C., Michallet, A.-S., Neidhardt-Berard, E.-M., Nicolas-Virelizier, E., Dufresne, A., Belhabri, A., Brahmi, M., Lebras, L., Nicolini, F., Sarabi, M., Rey, P., Bonneville-Levard, A., Rochefort, P., Provensal, A.-M., Eberst, L., Assaad, S., Swalduz, A., Saintigny, P., Toussaint, P., Guillermin, Y., Castets, M., Coutzac, C., Meeus, P., Dupré, A., Durand, T., Crochet, H., Fervers, B., Gomez, F., Rivoire, M., Gregoire, V., Claude, L., Chassagne-Clement, C., Pilleul, F., Mognetti, T., Russias, B., Soubirou, J.-L., Lasset, C., Chvetzoff, G., Mehlen, P., Beaupère, S., Zrounba, P., Ray-Coquard, I., Blay, J.-Y.

Source: In ESMO Open February 2021 6(1)

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Authors: Trédan, O., Wang, Q., Pissaloux, D., Cassier, P., de la Fouchardière, A., Fayette, J., Desseigne, F., Ray-Coquard, I., de la Fouchardière, C., Frappaz, D., Heudel, P.-E., Bonneville-Levard, A., Fléchon, A., Sarabi, M., Guibert, P., Bachelot, T., Pérol, M., You, B., Bonnin, N., Collard, O., Leyronnas, C., Attignon, V., Baudet, C., Sohier, E., Villemin, J.-P., Viari, A., Boyault, S., Lantuejoul, S., Paindavoine, S., Treillleux, I., Rodriguez, C., Agrapart, V., Corset, V., Garin, G., Chabaud, S., Pérol, D., Blay, J.-Y. ^*

Source: In Annals of Oncology May 2019 30(5):757-765

Development of a Rule Based Prognostic Tool for HER 2 Positive Breast Cancer Patients

Authors: Lisboa, P.J.G., Etchells, T.A., Jarman, I.H., Aung, M.S.H., Chabaud, S., Bachelot, T., Perol, D., Gargi, T., Bourdes, V., Bonnevay, S., Negrier, S.

Source: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society Engineering in Medicine and Biology Society, 2007. EMBS 2007. 29th Annual International Conference of the IEEE. :5416-5419 Aug, 2007

Relation: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society

Breast Cancer Predictions by Neural Networks Analysis: a Comparison with Logistic Regression

Authors: Bourdes, V.S., Bonnevay, S., Lisboa, P. J.G., Aung, M.S.H., Chabaud, S., Bachelot, T., Perol, D., Negrier, S.

Source: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society Engineering in Medicine and Biology Society, 2007. EMBS 2007. 29th Annual International Conference of the IEEE. :5424-5427 Aug, 2007

Relation: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society

Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancer

Authors: Lisboa, P.J.G., Etchells, T.A., Jarman, I.H., Aung, M.S.H., Chabaud, S., Bachelot, T., Perol, D., Gargi, T., Bourdes, V., Bonnevay, S., Negrier, S.

Source: 2007 International Joint Conference on Neural Networks Neural Networks, 2007. IJCNN 2007. International Joint Conference on. :2533-2538 Aug, 2007

Relation: 2007 International Joint Conference on Neural Networks (IJCNN)

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Authors: Jacquet, E., Lardy-Cléaud, A., Pistilli, B., Franck, S., Cottu, P., Delaloge, S., Debled, M., Vanlemmens, L., Leheurteur, M., Guizard, A.V., Laborde, L., Uwer, L., Jacot, W., Berchery, D., Desmoulins, I., Ferrero, J.M., Perrocheau, G., Courtinard, C., Brain, E., Chabaud, S., Robain, M., Bachelot, T.

Source: In European Journal of Cancer May 2018 95:93-101

55O IMADGIST: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

Authors: Le Cesne, A., Chabaud, S., Bouche, O., Penel, N., Brahmi, M., Toulmonde, M., Bompas, E., Bertucci, F., Chaigneau, L., Lahlou, W., Landi, B., Verret, B., Henon, C., Pannier, D., Pracht, M., Collard, O., Ray-Coquard, I.L., Metzger, S., Perol, D., Blay, J-Y.

Source: In ESMO Open March 2024 9 Supplement 2

52O Resistance to imatinib induced by treatment interruption in advanced GIST: Long-term outcome of the randomized BFR14 study

Authors: Blay, J-Y., Devin, Q., Duffaud, F., Toulmonde, M., Firmin, N., Collard, O., Bompas, E., Verret, B., Ray-Coquard, I.L., Salas, S., Henon, C., Honoré, C., Brahmi, M., Dufresne, A., Pracht, M., Penel, N., Perol, D., Chabaud, S., Italiano, A., Le Cesne, A.

Source: In ESMO Open March 2024 9 Supplement 2

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Authors: Trédan, O., Ménétrier-Caux, C., Ray-Coquard, I. ^*, Garin, G., Cropet, C., Verronèse, E., Bachelot, T., Rebattu, P., Heudel, P.E., Cassier, P., Chabaud, S., Croughs, T., Dupont, P., Cadore, A.C., Clapisson, G., Delgado, A., Bardin-dit-Courageot, C., Rigal, C., N'Kodia, A., Gilles-Afchain, L., Morre, M., Pérol, D., Blay, J.Y., Caux, C.

Source: In Annals of Oncology July 2015 26(7):1353-1362

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

Authors: Rochefort, P., Chabaud, S., Pierga, J. Y., Tredan, O., Brain, E., Bidard, F. C., Schiffler, C., Polena, H., Khalil-Mgharbel, A., Vilgrain, I.

Source: BRITISH JOURNAL OF CANCER. 116(3):356-361

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383417816&indx=1&recIds=ETOCRN383417816